Properties of incomplete carcinogens and promoters in hepatocarcinogenesis.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000494:pharmacology; D000818:Animals; D002273:Carcinogens / Q000008:administration & dosage / Q000494:pharmacology*; D003043:Cocarcinogenesis; D004052:Diethylnitrosamine / Q000494:pharmacology; D006498:Hepatectomy; D008099:Liver / Q000201:enzymology; D008113:Liver Neoplasms / Q000139:chemically induced*; D008749:Methyldimethylaminoazobenzene / Q000494:pharmacology; D009374:Neoplasms, Experimental / Q000139:chemically induced; D010634:Phenobarbital / Q000494:pharmacology; D010641:Phenotype; D051381:Rats
D002273:Carcinogens; D004052:Diethylnitrosamine; D008749:Methyldimethylaminoazobenzene; D015127:9,10-Dimethyl-1,2-benzanthracene; D010634:Phenobarbital